More about Aster DM Healthcare Limited
Fundamentals for Aster DM Healthcare Limited
Regulatory Filings for Aster DM Healthcare Limited
Why Oman Is Now India's Most Strategic Trade Partner
Infrastructure Bet Fuels Cement Surge
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
Fundamentals for Aster DM Healthcare Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates.
Revenue projections:
ASTERDM's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.
Financial Ratios:
| currentRatio | 1.98900 |
|---|---|
| forwardPE | 37.95156 |
| debtToEquity | 45.92100 |
| earningsGrowth | 0.71500 |
| revenueGrowth | 0.18200 |
| grossMargins | 0.58555 |
| operatingMargins | 0.13984 |
| trailingEps | 6.42000 |
| forwardEps | 19.15468 |
ASTERDM's current ratio of 1.989 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as ASTERDM can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
Aster DM Healthcare Limited's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that Aster DM Healthcare Limited is well-positioned for sustained growth in both profits and revenue.
ASTERDM's forward EPS exceeding its trailing EPS reflects expectations of increased profitability for the current year. This suggests that the company is projected to achieve higher earnings than in the previous financial year, signaling positive growth and improved financial health.
Price projections:
The current valuation of Aster DM Healthcare Limited, compared to projections, does not highlight any specific risks or opportunities. This stable scenario may lead investors to adopt a wait-and-see approach as they monitor future developments for potential shifts in the market.
Recommendation changes over time:
Analysts' buy bias for ASTERDM signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ASTERDM, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
How Independent Directors Failed Rs 2,500 Crore in Value